glp-1 and kidney Design discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis GLP-1 Receptor Agonists in the

People with those cancers who took liraglutide, pramlintide, dulaglutide, tirzepatide, lixisenatide, or semaglutide were 38% to 50% less likely to see the disease spread than people who took drugs from a different class of diabetes medicines known as gliptins

These results were also reported in other species including monkeys (concentration and route of administration not provided), rats (5% CGN in diet) and Guinea pigs (1% CGN in drinking water)

The same insurer applies opposite coverage logic: T2D indication broadly covered

IGF-1 promotes protein synthesis, enhances glucose uptake in skeletal muscle, stimulates lipolysis in adipose tissue, and plays crucial roles in tissue repair and regeneration